Concepedia

David Karpf

DK

Statistics

Publications

25

Citations

8.9K

H-Index

23

Active since

1980

Affiliations

Stanford University(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Ascendis Pharma (Denmark)

University of California, San Francisco

Brod Group

David Karpf is an author at Stanford University specializing in medicine, endocrinology, and bone metabolism.

Publications per year

1980–2021

25

Publications

25

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures

Dennis M. Black, Steven R. Cummings, David Karpf et al. · The Lancet · 1996 · 3.9K citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +12

Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis

Uri Liberman, Stuart Weiss, Johann Bröll et al. · New England Journal of Medicine · 1995 · 2.3K citations

Medicine, Endocrinology, Bone Metabolism +14

Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.

Patrick Garnero, W J Shih, Évelyne Gineyts et al. · The Journal of Clinical Endocrinology & Metabolism · 1994 · 682 citations · Full text

Medicine, Pharmacology, Bone Metabolism +16

Prevention of Nonvertebral Fractures by Alendronate

David Karpf · JAMA · 1997 · 281 citations

Medicine, Pharmacotherapy, Bone Augmentation +16

Early Changes in Biochemical Markers of Bone Turnover Predict the Long-Term Response to Alendronate Therapy in Representative Elderly Women: A Randomized Clinical Trial

Susan L. Greenspan, Robert A. Parker, Lauren Ferguson et al. · Journal of Bone and Mineral Research · 1998 · 240 citations

Medicine, Geriatric Medicine, Aging +16

1–5 of 25